Where is Oyster Point Pharma located?
Where is Oyster Point Pharma located?
Princeton, New Jersey
Based in Princeton, New Jersey, Oyster Point Pharma is a clinical stage pharmaceutical company leveraging neuroscience to discover, develop and commercialize novel therapies to treat diseases with high unmet needs.
Who owns Oyster Point?
Edric Mason
The Oyster Point Hotel is a 58-room hotel located on the Navesink River in Red Bank, New Jersey. The hotel was previously owned by Kevork Hovnanian and is currently owned by Edric Mason.
How many employees does Oyster Point Pharma have?
Latest Updates
| Employees (est.) (Dec 2019) | 30 | (+67%) |
|---|---|---|
| Share Price (Nov 2021) | $12.5 | |
| Cybersecurity rating | A | More |
When was Oyster Point Pharma founded?
2015
Oyster Point Pharma, named after the Oyster Point waterfront on San Francisco Bay, was founded in 2015 and is headquartered in Princeton, New Jersey.
What is ocular surface disorder?
DEFINITION. Ocular surface disease indicates damage to the surface layers of the eye, namely the cornea and conjunctiva. There are many causes ocular surface disease, but the 2 most common ones are “dry eye syndrome” and “blepharitis”.
Is dry eye an ocular surface disease?
Is ocular surface disease reversible?
Successful management of ocular surface disorders can be difficult. Many conditions, such as allergic eye diseases, are chronic. Symptoms can often be controlled but not completely eliminated. Relapse and flare-ups are also common, and most treatments require the involvement of the patient over a long period of time.
How can I hydrate my eyes?
Tips to Keep Your Eyes Hydrated
- Use artificial tears throughout the day if you are prone to dry eyes.
- Remember to blink when you use your computer, read, or play video games.
- Use a humidifier in your home during the fall and winter to keep the air moist.
- Stay away from cigarette smoke, which tends to dry out your eyes.
How do you manage ocular surface disease?
Steroid-sparing drugs (e.g. mycophenolate, azathioprine, cyclophosphamide) should be started when a prolonged disease course is expected. In ocular surface disease that is poorly controlled with topical therapy or where severe sub-acute inflammation persists, steroid-sparing therapy can be used without steroids.
How is severe ocular surface inflammation treated?
Three anti-inflammatory drugs are currently available to treat ocular surface disease: topical steroids, which are highly beneficial for acute ocular surface inflammation; the commercially available dry eye therapies, Restasis (Allergan) and Cequa (Sun Pharma), which are both cyclosporin formulations, and Xiidra ( …
